STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news

Two drugmakers asked the U.S. Supreme Court to restore mail-order access to the abortion pill mifepristone, after an appeals court suspended deliveries global health research Physicians Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Newsletter Pharmalot Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal,…

Source: STAT News Pharma